Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranilast in Sarcoidosis
NCT03528070Phase 1Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- May 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of tranilast in sarcoidosis, sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Changes in the size of the pulmonary nodule by ultrasound at 12 months and Changes of the forced vital capacity at 12 months. Status: unknown.
02
Drugs
tranilast
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on NCT03528070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03528070.